ENDRA Life Sciences Inc (NDRA) saw downtrend of -2.36% in the recent trading with $3.46 being its most recent. The current price level -97.97% lower than the highest price of $170.62 marked by the stock while trading over the past 52-weeks, whereas it is 19.19% higher than the lowest price of $2.90 the company dropped to over past 52-weeks. The latest news story on NDRA appeared in (Business Wire) under the title “ENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard” on Jun-16-25.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 1 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
ENDRA Life Sciences Inc Earnings – What Happened With NDRA
Coming around sales and income figures on NDRA Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
ENDRA Life Sciences Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 0.74 million. NDRA does have institutional investors; and they hold 0.25% of the stock.
Key Metrics forNDRA
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, ENDRA Life Sciences Inc has a debt to equity ratio of 0.34.
Technical Analysis of ENDRA Life Sciences Inc (NASDAQ:NDRA) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for ENDRA Life Sciences Inc (NDRA), we notice that the stock’s 20-day average volume is at 265,635 shares and 50% of short term indicators are suggesting the stock as Sell. Medium term indicators at an average of 100% are spotting the stock at Sell with its 50-day average volume of 190,974 shares. And to end, NDRA’s 100-day average volume is 162,454 shares with 100% of the long-term indicators pointing towards Sell for the stock.
